144 related articles for article (PubMed ID: 28375929)
21. Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.
De Strooper LMA; Verhoef VMJ; Berkhof J; Hesselink AT; de Bruin HME; van Kemenade FJ; Bosgraaf RP; Bekkers RLM; Massuger LFAG; Melchers WJG; Steenbergen RDM; Snijders PJF; Meijer CJLM; Heideman DAM
Gynecol Oncol; 2016 May; 141(2):341-347. PubMed ID: 26921784
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
[TBL] [Abstract][Full Text] [Related]
23. miR‑218 functions as a tumor suppressor gene in cervical cancer.
Liu Z; Mao L; Wang L; Zhang H; Hu X
Mol Med Rep; 2020 Jan; 21(1):209-219. PubMed ID: 31746391
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of HPV physical status and integration sites in cervical cancer.
Nambaru L; Meenakumari B; Swaminathan R; Rajkumar T
Asian Pac J Cancer Prev; 2009; 10(3):355-60. PubMed ID: 19640172
[TBL] [Abstract][Full Text] [Related]
25. Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study.
Zhang D; Zhang Q; Zhou L; Huo L; Zhang Y; Shen Z; Zhu Y
BMC Cancer; 2010 Nov; 10():650. PubMed ID: 21108842
[TBL] [Abstract][Full Text] [Related]
26. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
[TBL] [Abstract][Full Text] [Related]
28. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
Torres-Ibarra L; Cuzick J; Lorincz AT; Spiegelman D; Lazcano-Ponce E; Franco EL; Moscicki AB; Mahmud SM; Wheeler CM; Rivera-Paredez B; Hernández-López R; León-Maldonado L; Salmerón J;
JAMA Netw Open; 2019 Nov; 2(11):e1915781. PubMed ID: 31747033
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.
Perez Castro S; Iñarrea Fernández A; Lamas González MJ; Sarán Diez MT; Cid Lama A; Alvarez Martín MJ; Pato Mosquera M; López-Miragaya I; Estévez N; Torres Piñón J; Oña Navarro M
J Med Virol; 2013 Jun; 85(6):1063-8. PubMed ID: 23588733
[TBL] [Abstract][Full Text] [Related]
30. [Infection of human papillomavirus 16/18 DNA in patients with head and neck squamous cell carcinoma and its relationship with expression of Ki-67 and P53 protein].
Zhang JL; Sun Z; Huo Z; Luo YF; Ma SQ; Wang DT; Cao JL; Yang T; Cui QC; Bai CM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug; 32(4):429-32. PubMed ID: 20868604
[TBL] [Abstract][Full Text] [Related]
31. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women.
Correnti M; Medina F; Cavazza ME; Rennola A; Avila M; Fernándes A
Gynecol Oncol; 2011 Jun; 121(3):527-31. PubMed ID: 21421263
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India.
Patel KR; Vajaria BN; Begum R; Desai A; Patel JB; Shah FD; Shukla SN; Patel PS
J Oral Pathol Med; 2014 Apr; 43(4):293-7. PubMed ID: 24372728
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus type distribution in cervical cancer in Delhi, India.
Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
[TBL] [Abstract][Full Text] [Related]
36. The correlation between FHIT, P53 and MMR genes in human papillomavirus-associated cervical carcinoma.
Bahnassy AA; Zekri AR; Madbouly MS; El-Naggar M; El-Khelany ZF; El-Merzebany MM
J Egypt Natl Canc Inst; 2006 Sep; 18(3):191-202. PubMed ID: 17671528
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of human papillomavirus types 16 and 18 DNA physical status in cervical intraepithelial neoplasia.
Gradíssimo Oliveira A; Delgado C; Verdasca N; Pista A
Clin Microbiol Infect; 2013 Oct; 19(10):E447-50. PubMed ID: 23659555
[TBL] [Abstract][Full Text] [Related]
38. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
40. Comparison of treatment response in cervical carcinoma patients infected with human papillomavirus 16 and human papillomavirus 18 who are treated with chemoradiation.
Narayanan GS; Ganesh MS; Kumar R
J Cancer Res Ther; 2021; 17(1):204-210. PubMed ID: 33723156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
